118 related articles for article (PubMed ID: 38514045)
21. Investigation of non-motor symptoms in first-degree relatives of patients with Parkinson's disease.
Liu JB; Leng JL; Zhang XJ; Wang ZX; Duan ZW; Mao CJ; Liu CF
Parkinsonism Relat Disord; 2018 Jul; 52():62-68. PubMed ID: 29606605
[TBL] [Abstract][Full Text] [Related]
22. Anxiety is associated with cognitive impairment in newly-diagnosed Parkinson's disease.
Dissanayaka NNW; Lawson RA; Yarnall AJ; Duncan GW; Breen DP; Khoo TK; Barker RA; Burn DJ;
Parkinsonism Relat Disord; 2017 Mar; 36():63-68. PubMed ID: 28108263
[TBL] [Abstract][Full Text] [Related]
23. Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD).
Riedel O; Klotsche J; Spottke A; Deuschl G; Förstl H; Henn F; Heuser I; Oertel W; Reichmann H; Riederer P; Trenkwalder C; Dodel R; Wittchen HU
J Neurol; 2008 Feb; 255(2):255-64. PubMed ID: 18204803
[TBL] [Abstract][Full Text] [Related]
24. The Impact of Sex-Specific Survival on the Incidence of Dementia in Parkinson's Disease.
Fink A; Dodel R; Georges D; Doblhammer G
Mov Disord; 2023 Nov; 38(11):2041-2052. PubMed ID: 37658585
[TBL] [Abstract][Full Text] [Related]
25. Prodromal Parkinsonism and Neurodegenerative Risk Stratification in REM Sleep Behavior Disorder.
Barber TR; Lawton M; Rolinski M; Evetts S; Baig F; Ruffmann C; Gornall A; Klein JC; Lo C; Dennis G; Bandmann O; Quinnell T; Zaiwalla Z; Ben-Shlomo Y; Hu MTM
Sleep; 2017 Aug; 40(8):. PubMed ID: 28472425
[TBL] [Abstract][Full Text] [Related]
26. Association between Sleep Factors and Parkinson's Disease: A Prospective Study Based on 409,923 UK Biobank Participants.
Chen Y; Gao Y; Sun X; Wang BH; Qin L; Wu IX; Li G
Neuroepidemiology; 2023; 57(5):293-303. PubMed ID: 37231899
[TBL] [Abstract][Full Text] [Related]
27. Mild cognitive impairment in Parkinson's disease: the Parkinson's disease cognitive study (PACOS).
Monastero R; Cicero CE; Baschi R; Davì M; Luca A; Restivo V; Zangara C; Fierro B; Zappia M; Nicoletti A
J Neurol; 2018 May; 265(5):1050-1058. PubMed ID: 29478221
[TBL] [Abstract][Full Text] [Related]
28. Risk and adverse outcomes of fractures in patients with Parkinson's disease: two nationwide studies.
Huang YF; Cherng YG; Hsu SP; Yeh CC; Chou YC; Wu CH; Chen TL; Liao CC
Osteoporos Int; 2015 Jun; 26(6):1723-32. PubMed ID: 25672807
[TBL] [Abstract][Full Text] [Related]
29. Predictors of anxiety in early-stage Parkinson's disease - Results from the first two years of a prospective cohort study.
Rutten S; van der Ven PM; Weintraub D; Pontone GM; Leentjens AFG; Berendse HW; van der Werf YD; van den Heuvel OA
Parkinsonism Relat Disord; 2017 Oct; 43():49-55. PubMed ID: 28711192
[TBL] [Abstract][Full Text] [Related]
30. Identification of Prodromal Presentations of Parkinson's Disease among Primary Care Outpatients in Germany.
Bohlken J; Schrag A; Riedel-Heller S; Kostev K
Neuroepidemiology; 2022; 56(1):41-49. PubMed ID: 34724667
[TBL] [Abstract][Full Text] [Related]
31. Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPaMiP study.
Nègre-Pagès L; Grandjean H; Lapeyre-Mestre M; Montastruc JL; Fourrier A; Lépine JP; Rascol O;
Mov Disord; 2010 Jan; 25(2):157-66. PubMed ID: 19950403
[TBL] [Abstract][Full Text] [Related]
32. Premotor symptoms and the risk of Parkinson's disease: A case-control study in Mexican population.
Rodríguez-Violante M; de Saráchaga AJ; Cervantes-Arriaga A; Davila-Avila NM; Carreón-Bautista E; Estrada-Bellmann I; Parra-López G; Cruz-Fino D; Pascasio-Astudillo F
Clin Neurol Neurosurg; 2017 Sep; 160():46-49. PubMed ID: 28644969
[TBL] [Abstract][Full Text] [Related]
33. Detecting Non-cognitive Features of Prodromal Neurodegenerative Diseases.
Seifan A; Ganzer CA; Ryon K; Lin M; Mahmudur R; Adolfo H; Shih C; Jacobs AR; Greenwald M; Isaacson RS
Curr Aging Sci; 2019; 11(4):242-249. PubMed ID: 30845903
[TBL] [Abstract][Full Text] [Related]
34. Non-recognition of depression and other non-motor symptoms in Parkinson's disease.
Shulman LM; Taback RL; Rabinstein AA; Weiner WJ
Parkinsonism Relat Disord; 2002 Jan; 8(3):193-7. PubMed ID: 12039431
[TBL] [Abstract][Full Text] [Related]
35. Study protocol for the MIND-PD study: a randomized controlled trial to investigate clinical and biological effects of mindfulness-based cognitive therapy in people with Parkinson's disease.
van der Heide A; Goltz F; de Vries NM; Bloem BR; Speckens AE; Helmich RC
BMC Neurol; 2024 Jun; 24(1):219. PubMed ID: 38918695
[TBL] [Abstract][Full Text] [Related]
36. Visual Impairment Is More Common in Parkinson's Disease and Is a Risk Factor for Poor Health Outcomes.
Hamedani AG; Abraham DS; Maguire MG; Willis AW
Mov Disord; 2020 Sep; 35(9):1542-1549. PubMed ID: 32662528
[TBL] [Abstract][Full Text] [Related]
37. Mortality of People with Parkinson's Disease in a Large UK-Based Cohort Study: Time Trends and Relationship to Disease Duration.
Okunoye O; Horsfall L; Marston L; Walters K; Schrag A
Mov Disord; 2021 Dec; 36(12):2811-2820. PubMed ID: 34351000
[TBL] [Abstract][Full Text] [Related]
38. Relationships among cognitive impairment, sleep, and fatigue in Parkinson's disease using the MDS-UPDRS.
Goldman JG; Stebbins GT; Leung V; Tilley BC; Goetz CG
Parkinsonism Relat Disord; 2014 Nov; 20(11):1135-9. PubMed ID: 25150770
[TBL] [Abstract][Full Text] [Related]
39. Cerebrospinal fluid inflammatory markers in Parkinson's disease--associations with depression, fatigue, and cognitive impairment.
Lindqvist D; Hall S; Surova Y; Nielsen HM; Janelidze S; Brundin L; Hansson O
Brain Behav Immun; 2013 Oct; 33():183-9. PubMed ID: 23911592
[TBL] [Abstract][Full Text] [Related]
40. Clinical determinants of primary and secondary fatigue in patients with Parkinson's disease.
Skorvanek M; Nagyova I; Rosenberger J; Krokavcova M; Ghorbani Saeedian R; Groothoff JW; Gdovinova Z; van Dijk JP
J Neurol; 2013 Jun; 260(6):1554-61. PubMed ID: 23299623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
